A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid (Q39728479)
Jump to navigation
Jump to search
scientific article published on May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid |
scientific article published on May 2010 |
Statements
1 reference
A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid (English)
1 reference
1 reference
John V Heymach
1 reference
Peter E Zage
1 reference
Lizhi Zeng
1 reference
Shana Palla
1 reference
Wendy Fang
1 reference
Monique B Nilsson
1 reference
1 May 2010
1 reference
2465-2475
1 reference
1 reference
Identifiers
1 reference